Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: CEREP

Market Cap 77.17M 88.57M 71.14M 66.91M 125M 8.35B 126M 846M 329M 4.11B 332M 325M 14.26B P/E 2024 *
-
P/E 2025 -
Enterprise Value 56.14M 64.43M 51.75M 48.68M 91.06M 6.07B 91.7M 616M 239M 2.99B 242M 237M 10.37B EV / Sales 2024
2.02x
EV / Sales 2025 1.67x
Free-Float
4.22%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - 2024-04-10
Director TitleAgeSince
Chairman - 2023-08-10
Director/Board Member - 2024-05-22
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
-0.34%-0.08%-12.15%-13.39% 43.44B
+3.31%+9.22%+308.19%+562.02% 33.54B
+2.84%+3.80%+6.87%+34.93% 29.2B
-1.70%-7.34%+8.51%-22.34% 28.48B
-0.57%+4.45%+12.31%+20.42% 25.34B
-0.14%+7.06% - - 14.36B
+0.68%-3.13%+52.04%+107.47% 13.05B
+0.54%-2.27%+3.93%+2.24% 12.67B
-0.26%+0.41%+100.27%+80.69% 12.28B
Average +0.48%+1.38%+60.00%+96.51% 23.6B
Weighted average by Cap. +0.60%+1.40%+63.25%+109.05%

Financials

2024 2025
Net sales 40.49M 46.47M 37.32M 35.11M 65.68M 4.38B 66.14M 444M 172M 2.16B 174M 171M 7.48B 41.1M 47.17M 37.89M 35.64M 66.67M 4.45B 67.14M 451M 175M 2.19B 177M 173M 7.59B
Net income 7.15M 8.21M 6.6M 6.2M 11.61M 774M 11.69M 78.47M 30.47M 381M 30.82M 30.16M 1.32B 4.78M 5.49M 4.41M 4.15M 7.76M 517M 7.81M 52.45M 20.37M 255M 20.6M 20.16M 884M
Net Debt -17.25M -19.8M -15.9M -14.96M -27.99M -1.87B -28.18M -189M -73.49M -920M -74.32M -72.73M -3.19B -21.03M -24.14M -19.39M -18.24M -34.12M -2.28B -34.36M -231M -89.59M -1.12B -90.62M -88.68M -3.89B
Logo CEREP
Eurofins Cerep specializes in the pre-clinical research of drugs for the pharmaceutical industry. Export accounts for 88.2% of net sales.
Employees
-
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!